Compare
Regentis Biomaterials Ltd. vs NutriBand Inc. vs Milestone Scientific Inc. vs Envoy Medical, Inc.
| Latest fiscal year | Regentis Biomaterials Ltd. RGNT | NutriBand Inc. NTRB | Milestone Scientific Inc. MLSS | Envoy Medical, Inc. COCH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-01-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $2.04M | $8.97M | $241.0K |
| Revenue growth (YoY) | n/a | -4.8% | +4.0% | +7.1% |
| Gross margin | n/a | 27.8% (computed) | 71.4% | -262.7% (computed) |
| Operating margin | n/a | -408.4% | -63.5% | n/m |
| Net margin | n/a | -404.1% | -63.8% | n/m |
| Net income | -$13.65M | -$8.23M | -$5.72M | -$23.76M |
| EPS (Diluted) | -$24.16 | -$2.58 | -$0.07 | -$1.23 |
| Operating cash flow | -$1.38M | -$5.13M | -$2.92M | -$18.20M |
| Free cash flow | n/a | -$5.14M | -$2.93M | -$18.38M |
| Cash & equivalents | $7.38M | $4.57M | $1.11M | n/a |
| Total assets | $7.62M | $7.55M | $7.81M | $8.56M |
| Total liabilities | $2.87M | $868.4K | $4.99M | $20.32M |
| Shareholders' equity | $4.74M | $6.68M | $2.81M | -$12.16M |
| Return on year-end equity | -287.7% | -123.2% | -203.4% | n/a |
| Shares outstanding | 5.18M | 12.16M | 80.45M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Regentis Biomaterials Ltd. | NutriBand Inc. | Milestone Scientific Inc. | Envoy Medical, Inc. |
|---|---|---|---|---|
| Latest | n/a | $2.04M Ended 2026-01-31 | $8.97M Ended 2025-12-31 | $241.0K Ended 2025-12-31 |
| 1 year earlier | n/a | $2.14M Ended 2025-01-31 | $8.63M Ended 2024-12-31 | $225.0K Ended 2024-12-31 |
| 2 years earlier | n/a | $2.09M Ended 2024-01-31 | $9.83M Ended 2023-12-31 | $316.0K Ended 2023-12-31 |
| 3 years earlier | n/a | $2.08M Ended 2023-01-31 | $8.81M Ended 2022-12-31 | $237.0K Ended 2022-12-31 |
| 4 years earlier | n/a | $1.42M Ended 2022-01-31 | $10.30M Ended 2021-12-31 | n/a |